Search research articles
Contact Us
Filters
Showing results (11-20 of 57) with videos related to
Page
of 6
Sort By:
Leukemia & Lymphoma
|
December 28, 1999
Oral idarubicin as a single agent therapy in patients with relapsed or resistant multiple myeloma
K Sumpter, R L Powles, N Raje, et al.
Leukemia
|
October 24, 2013
Induction of differential apoptotic pathways in multiple myeloma cells by class-selective histone deacetylase inhibitors
T Hideshima, R Mazitschek, L Santo, et al.
Bone Marrow Transplantation
|
October 1, 1995
Kinetics of paraprotein clearance after autografting for multiple myeloma
S Singhal, R Powles, S Milan, et al.
Leukemia & Lymphoma
|
July 1, 1994
Adult acute lymphoblastic leukemia: results of an aggressive regimen in India
N Raje, S Pai, S Vaidya, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 31, 2000
Characterization of signaling cascades triggered by human interleukin-6 versus Kaposi's sarcoma-associated herpes virus-encoded viral interleukin 6
T Hideshima, D Chauhan, G Teoh, et al.
Leukemia & Lymphoma
|
May 1, 1996
Comparison of interferon tolerance after autologous bone marrow or peripheral blood stem cell transplants for myeloma patients who have responded to induction therapy
R Powles, N Raje, C Horton, et al.
Bone Marrow Transplantation
|
May 9, 2000
Acute lymphoblastic leukaemia-type intensive chemotherapy to eliminate minimal residual disease after high-dose melphalan and autologous transplantation in multiple myeloma - a phase I/II feasibility and tolerance study of 17 patients
R Powles, B Sirohi, S Kulkarni, et al.
Stem Cells (Dayton, Ohio)
|
August 1, 1995
Maintenance therapy for remission in myeloma with Intron A following high-dose melphalan and either an autologous bone marrow transplantation or peripheral stem cell rescue
R Powles, N Raje, D Cunningham, et al.
British Journal of Haematology
|
December 3, 1999
Complete remission rate and outcome after intensive treatment of 177 patients under 75 years of age with IgG myeloma defining a circumscribed disease entity with a new staging system
B Sirohi, R Powles, J Mehta, et al.
British Journal of Cancer
|
January 1, 1997
Comparison of marrow vs blood-derived stem cells for autografting in previously untreated multiple myeloma
N Raje, R Powles, C Horton, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 57) with videos related to
Sort By:
Page
of 6
Leukemia & Lymphoma
|
December 28, 1999
Oral idarubicin as a single agent therapy in patients with relapsed or resistant multiple myeloma
K Sumpter, R L Powles, N Raje, et al.
Leukemia
|
October 24, 2013
Induction of differential apoptotic pathways in multiple myeloma cells by class-selective histone deacetylase inhibitors
T Hideshima, R Mazitschek, L Santo, et al.
Bone Marrow Transplantation
|
October 1, 1995
Kinetics of paraprotein clearance after autografting for multiple myeloma
S Singhal, R Powles, S Milan, et al.
Leukemia & Lymphoma
|
July 1, 1994
Adult acute lymphoblastic leukemia: results of an aggressive regimen in India
N Raje, S Pai, S Vaidya, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 31, 2000
Characterization of signaling cascades triggered by human interleukin-6 versus Kaposi's sarcoma-associated herpes virus-encoded viral interleukin 6
T Hideshima, D Chauhan, G Teoh, et al.
Leukemia & Lymphoma
|
May 1, 1996
Comparison of interferon tolerance after autologous bone marrow or peripheral blood stem cell transplants for myeloma patients who have responded to induction therapy
R Powles, N Raje, C Horton, et al.
Bone Marrow Transplantation
|
May 9, 2000
Acute lymphoblastic leukaemia-type intensive chemotherapy to eliminate minimal residual disease after high-dose melphalan and autologous transplantation in multiple myeloma - a phase I/II feasibility and tolerance study of 17 patients
R Powles, B Sirohi, S Kulkarni, et al.
Stem Cells (Dayton, Ohio)
|
August 1, 1995
Maintenance therapy for remission in myeloma with Intron A following high-dose melphalan and either an autologous bone marrow transplantation or peripheral stem cell rescue
R Powles, N Raje, D Cunningham, et al.
British Journal of Haematology
|
December 3, 1999
Complete remission rate and outcome after intensive treatment of 177 patients under 75 years of age with IgG myeloma defining a circumscribed disease entity with a new staging system
B Sirohi, R Powles, J Mehta, et al.
British Journal of Cancer
|
January 1, 1997
Comparison of marrow vs blood-derived stem cells for autografting in previously untreated multiple myeloma
N Raje, R Powles, C Horton, et al.
Page
of 6